Announcement

Collapse
No announcement yet.

Acorda filed an IND for fampridine sr today.

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Acorda filed an IND for fampridine sr today.

    That would be the sustained release kind of 4ap, which is said to have fewer side effects. For those people with sci who couldn't handle the immediate release version but felt that it was helping them, this is good news.

    However, the pace is glacial.


    The company expects a standard 10-month review at the FDA, meaning Fampridine-SR could gain marketing approval late this year.
    source

  • #2
    10 months ... holy crap!
    Roses are red. Tacos are enjoyable. Don't blame immigrants, because you're unemployable.

    T-11 Flaccid Paraplegic due to TM July 1985 @ age 12

    Comment

    Working...
    X